Join
Live feed
·
PRReleasevia Quantisnow
Atento S.A. logo

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

ByQuantisnow·Wall Street's wire, on your screen.
ATTO· Atento S.A.
Telecommunications

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATTO (Atento S.A.) and more on Quantisnow.